Literature DB >> 36153441

ASO Author Reflections: Intraoperative Anticancer Therapy for Resected Gastric Cancer.

Shouki Bazarbashi1.   

Abstract

Entities:  

Year:  2022        PMID： 36153441     DOI： 10.1245/s10434-022-12520-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  5 in total

1.  Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.

Authors:  R Hamazoe; M Maeta; N Kaibara
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

2.  Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.

Authors:  Y Yonemura; X de Aretxabala; T Fujimura; S Fushida; K Katayama; E Bandou; K Sugiyama; T Kawamura; K Kinoshita; Y Endou; T Sasaki
Journal:  Hepatogastroenterology       Date:  2001 Nov-Dec

3.  Benefits from adjuvant intraoperative radiotherapy treatment for gastric cancer: A meta-analysis.

Authors:  Wei-Wei Yu; Yan-Mei Guo; Qing Zhang; Shen Fu
Journal:  Mol Clin Oncol       Date:  2014-10-13

4.  ASO Visual Abstract: Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer-A Comparative Nonrandomized Study.

Authors:  Shouki Bazarbashi; Ahmed Badran; Ahmed Mostafa Gad; Ali Aljubran; Ahmed Alzahrani; Aisha Alshibani; Reem Alrakaf; Tusneem Elhassan; Abdullah Alsuhaibani; Mahmoud A Elshenawy
Journal:  Ann Surg Oncol       Date:  2022-09-04       Impact factor: 4.339

5.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Authors:  Xiao-Jun Yang; Chao-Qun Huang; Tao Suo; Lie-Jun Mei; Guo-Liang Yang; Fu-Lin Cheng; Yun-Feng Zhou; Bin Xiong; Yutaka Yonemura; Yan Li
Journal:  Ann Surg Oncol       Date:  2011-03-23       Impact factor: 5.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.